01963nam a2200337   4500001000700000010001800007090001100025100004100036101000800077200010200085210010700187215002000294300004900314330073700363606003201100606003001132606003201162606003701194606003001231606002101261606002001282606002801302606002201330606002101352606002201373606002701395606002001422710005401442955001101496995011801507394298  a9789284613473  a394298  a20161221d2016       y0pory50      ba  aeng  aA review and assessment of EU drug policybRecurso eletrónicoestudyfMirja Gutheil ...[et al.]  aBrusselscEuropean Parliament. Policy Department for Citizen's Rights and Constitutional Affairsd2016  a1 CD-ROMd12 cm  aFicheiro de 2,41 MB em formato PDF (224 p.).  aExecutive Summary. 1. Introduction and Methodology. 2. International Drug Policy Overview. 3. Eu Legal and Policy Framework. 4. Member State Drug Policies. 5. Effectiveness and Added Value of Drug Policy. 6. Observations, Recommendations and Policy Proposals. References. Appendix A: Eu Case Studies. Appendix A1: Case Study – Czech Republic. Appendix A2: Case Study – Germany. Appendix A3: Case Study – Spain. Appendix A4: Case Study – Netherlands. Appendix A5: Case Study – Poland. Appendix A6: Case Study – Portugal. Appendix A7: Case Study – Sweden. Appendix B: Non-Eu Case Studies. Appendix B1: Case Study – Switzerland. Appendix B2: Case Study – United States Of America. Appendix B3: Case Study – Uruguay.  aTOXICODEPENDÊNCIA9225048  aCOMBATE À DROGA9410441  aPOLÍTICA CRIMINAL9231088  aPOLÍTICA COMUNITÁRIA9232791  aREPÚBLICA CHECA9333273  aALEMANHA9333241  aESPANHA9330771  aPAÍSES BAIXOS9339645  aPOLÓNIA9333222  aSUÉCIA9334325  aSUÍÇA9336290  aESTADOS UNIDOS9334103  aURUGUAI9333590  aA REVIEW AND ASSESSMENT OF EU DRUG POLICY9358316  xOferta  104PJCD_282_00000000000000052022-06-066PJCD2829426907aPJcPJfPJ1CD282_92kPJCD282n2022-06-06o0rMOxOferta